Skip to main content

IDWeek 2021 Main banner

Tweets by IDWeek 2021

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Victoria Catterson, PhD

BioSymetrics, Inc
New York, New York, United States

Humanigen, Inc (Consultant)

Presentation(s):

40 - Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial

On Demand